Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
5.01
0.00 (0.00%)
Jan 17, 2025, 4:00 PM EST - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $69.12 million as of January 17, 2025. Its market cap has decreased by -63.71% in one year.
Market Cap
69.12M
Enterprise Value
56.49M
1-Year Change
-63.71%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $69.12M, an increase of 10.58%. That is a compound annual growth rate of 2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 69.12M | -0.40% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |